1528TiP A phase II/III study evaluating the efficacy and safety of unesbulin in advanced leiomyosarcoma (SUNRISELMS)

Ingham, M., Blay, J.-Y., Baird, J., D’Silva, D., O’Keefe, K., Kong, R., Spiegel, R., Wahba, M., & Weetall, M. (2022). 1528TiP A phase II/III study evaluating the efficacy and safety of unesbulin in advanced leiomyosarcoma (SUNRISELMS). Annals of Oncology, 33, S1243–S1244. https://doi.org/10.1016/j.annonc.2022.07.1917
Authors:
M. Ingham
Jean‐Yves Blay
J. Baird
D. D'Silva
K. O'Keefe
R. Kong
R. Spiegel
M. Wahba
M. Weetall
Affiliated Authors:
M. Ingham
Columbia Affiliation:
Subjects:
Sarcoma Research and Treatment (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Lymphoid Neoplasms (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2022.07.1917
DOI:
10.1016/j.annonc.2022.07.1917
Journal:
Annals of Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: